Search hospitals > Ohio > Sylvania

Toledo Center For Clinical Research

Claim this profile
Sylvania, Ohio 43560
Global Leader in Asthma
Conducts research for Chronic Urticaria
Conducts research for Allergic Rhinitis
Conducts research for Hereditary Angioedema
Conducts research for Angioedema
37 reported clinical trials
0 medical researchers
Photo of Toledo Center For Clinical Research in SylvaniaPhoto of Toledo Center For Clinical Research in SylvaniaPhoto of Toledo Center For Clinical Research in Sylvania

Summary

Toledo Center For Clinical Research is a medical facility located in Sylvania, Ohio. This center is recognized for care of Asthma, Chronic Urticaria, Allergic Rhinitis, Hereditary Angioedema, Angioedema and other specialties. Toledo Center For Clinical Research is involved with conducting 37 clinical trials across 30 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at Toledo Center For Clinical Research

Asthma
Chronic Urticaria
Clostridium Difficile Infection
Diarrhea
Clostridium difficile infection
C. diff infection
Clostridioides difficile Infection
C. difficile Infection
Clostridium Difficile
Medical Device Site Urticaria
Image of trial facility.

Dupilumab

for Asthma

This trial is testing dupilumab, a medication that reduces lung inflammation, in adults with moderate to severe asthma that isn't controlled by usual treatments. It aims to see if dupilumab can help improve breathing and slow down lung damage.
Recruiting2 awards Phase 48 criteria
Image of trial facility.

Lunsekimig

for Asthma

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have previously completed the parent studies. After completion of the parent study, eligible participants will be offered the opportunity to participate in the long-term extension (LTE) study with lunsekimig. The study duration will be up to 100 weeks with a treatment duration being up to 96 weeks.
Recruiting1 award Phase 21 criteria
Image of trial facility.

Lunsekimig

for Asthma

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, who are not currently eligible for biologic treatments. Study details include: * The study duration will be approximately 64 weeks for participants not transitioning into the LTS study and approximately 60 weeks for participants transitioning into the LTS study. * The investigational treatment duration will be up to approximately 52 weeks. * The number of visits will be 18.
Recruiting0 awards Phase 26 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Toledo Center For Clinical Research?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security